Seminar - “Size Matters: Developing Design Rules to Engineer Nanoparticles for Solid Tumour Targeting" by Edward A Sykes, Institute of Biomaterials and Biomedical Engineering, University of Toronto
ABSTRACT: Nanotechnology offers highly customizable platforms for producing minimally invasive and programmable strategies to diagnose and treat cancer. Advances in this field have demonstrated that nanoparticles can enhance specificity of anti-cancer agents, respond to tumour-specific cues, and direct the visualization of biological targets in vivo.